Recombinant Vibrio vulnificus Acetylornithine aminotransferase (argD)

Shipped with Ice Packs
In Stock

Description

Overview

Recombinant Vibrio vulnificus Acetylornithine aminotransferase (argD) is an enzyme that belongs to the aspartate aminotransferase family of proteins . The argD gene encodes this enzyme in Vibrio vulnificus, a bacterium known to cause severe infections in humans, including septicemia, wound infections, and gastroenteritis .

Characteristics

  • Purity Recombinant Vibrio vulnificus Acetylornithine aminotransferase (argD) typically has a purity level of greater than or equal to 85%, as determined by SDS-PAGE .

  • Host Organisms This recombinant protein can be expressed in various host organisms, including E. coli, yeast, baculovirus, or mammalian cells .

  • Role in Metabolism Acetylornithine aminotransferase (ArgD) is involved in the biosynthesis of arginine, an essential amino acid. Specifically, it catalyzes the transamination reaction that converts N-acetylornithine to N-acetylglutamate-gamma-semialdehyde .

Vibrio vulnificus and its Virulence

Vibrio vulnificus is a zoonotic bacterium responsible for 95% of all seafood-related deaths in the United States . V. vulnificus can cause highly lethal diseases in humans . Some V. parahaemolyticus strains have two major virulence genes (tdh and trh) encoding thermostable direct hemolysin (TDH) and TDH-related hemolysin .

Arylamine N-acetyltransferases (NATs) in V. vulnificus

Arylamine N-acetyltransferases (NATs) are xenobiotic-metabolizing enzymes that biotransform aromatic amine chemicals .

  • Sequence Analysis V. vulnificus NAT (VIBVN) has a typical Cys-His-Asp catalytic triad, which participates in arylamine acetylation .

  • (VIBVN)NAT Activity (VIBVN)NAT could acetylate various aromatic amine substrates and contribute to arylamine antibiotic resistance in V. vulnificus .

  • Kinetic Parameters The kinetic parameters measured for (VIBVN)NAT are determined from Michaelis–Menten kinetics plots .

    • The $$K_m$$ value reflects the binding affinity between the substrate and the enzyme .

  • Inhibition The enzyme activity was significantly inhibited by $$Zn^{2+}$$ and $$Cu^{2+}$$ .

Product Specs

Form
Lyophilized powder
Note: We will prioritize shipping the format currently in stock. If you require a specific format, please specify this in your order notes; we will fulfill your request to the best of our ability.
Lead Time
Delivery times vary depending on the purchase method and location. Please contact your local distributor for precise delivery estimates.
Note: All proteins are shipped with standard blue ice packs. Dry ice shipping requires prior arrangement and incurs additional charges.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Before opening, briefly centrifuge the vial to collect the contents. Reconstitute the protein in sterile, deionized water to a concentration of 0.1-1.0 mg/mL. For long-term storage, we recommend adding 5-50% glycerol (final concentration) and aliquoting at -20°C/-80°C. Our standard glycerol concentration is 50% and can serve as a guideline.
Shelf Life
Shelf life depends on several factors including storage conditions, buffer composition, temperature, and the inherent stability of the protein. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized forms have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
The tag type is determined during the manufacturing process.
The tag type is determined during production. If you have a specific tag requirement, please inform us; we will prioritize the development of your specified tag.
Synonyms
argD; VV3054Acetylornithine aminotransferase; ACOAT; EC 2.6.1.11
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-403
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Vibrio vulnificus (strain YJ016)
Target Names
argD
Target Protein Sequence
MTVEMKVERG LFDEVMVPCY NPMEMIPVKG QGSRIWDQNG NEYIDFAGGI AVSCLGHCHP VMVNALTEQA GKLWHLSNVM TNEPALRLAK KLTEVSFAER VFFANSGAEA NEAALKLARR YAADVYGPEK SEIIAFKQGF HGRTFFTVTV GGQAAYSDGF GPKPGDVTHL PYNDIEALQA HISDRTCAVM MEPLQGEGGI IPPTAEFIQA VRELCDKHNA LLVFDEVQTG NGRTGEFYAY QGLGVTPDIL STAKSLGGGF PIGAMLTTAK LAEHLKVGTH GSTYGGNPLA CAVAEAVVTE VSKPETLQGV KEREQWFREG LAKLNEKYQI FAEIRGKGLL LGAALNEQWQ GRARDVLVAA GKEGLLVLVA GANVVRFTPS LVITKQEIEE GFAKLDKAIA SLV
Uniprot No.

Target Background

Database Links

KEGG: vvy:VV3054

Protein Families
Class-III pyridoxal-phosphate-dependent aminotransferase family, ArgD subfamily
Subcellular Location
Cytoplasm.

Q&A

What is Vibrio vulnificus Acetylornithine aminotransferase (argD) and what is its role in bacterial metabolism?

Acetylornithine aminotransferase (argD) is a pyridoxal phosphate-dependent enzyme that catalyzes the transamination of N-acetylornithine to N-acetylglutamate semialdehyde in the arginine biosynthesis pathway of Vibrio vulnificus. This reaction represents a critical step in the arginine biosynthesis pathway, which is essential for bacterial growth and survival. Unlike N-acetyltransferases (NAT) which transfer acetyl groups from acetyl-CoA to arylamine substrates, argD specifically handles the transamination reaction in amino acid metabolism.

In V. vulnificus, argD is particularly important as this pathogen requires efficient amino acid metabolism for virulence and survival in various environmental conditions. The enzyme's function should be considered within the broader context of V. vulnificus metabolism, which research has shown includes notable features like overflow metabolism and acetate excretion under certain conditions .

How can I optimize the heterologous expression of Vibrio vulnificus argD?

Optimizing heterologous expression of V. vulnificus argD requires careful consideration of several factors:

  • Expression system selection: E. coli BL21(DE3) is typically recommended due to its reduced protease activity and compatibility with T7 promoter-based expression systems.

  • Vector design: Include a His-tag or other affinity tag for purification purposes. Consider codon optimization based on the expression host's preferences since V. vulnificus has different codon usage patterns than common expression hosts.

  • Growth conditions: Based on studies with other V. vulnificus proteins such as NAT, optimal growth conditions typically include:

    • Temperature: 25-30°C after induction (lower temperatures often improve solubility)

    • Media: LB medium supplemented with appropriate antibiotics

    • Induction: 0.1-0.5 mM IPTG at OD600 of 0.6-0.8

    • Post-induction growth: 4-16 hours

  • Buffer optimization: For aminotransferases, including 20-50 μM pyridoxal-5'-phosphate (PLP) in buffers is crucial to maintain enzyme activity.

How does the structure of Vibrio vulnificus argD compare to other bacterial aminotransferases?

While specific structural data for V. vulnificus argD is limited, aminotransferases generally share a conserved architecture. Based on sequence alignment approaches similar to those used for V. vulnificus NAT , we can infer several key features:

  • Catalytic residues: Like other aminotransferases, V. vulnificus argD likely contains a conserved lysine residue that forms a Schiff base with the PLP cofactor.

  • Domain structure: Aminotransferases typically have two domains:

    • A larger domain containing most of the PLP binding site

    • A smaller domain involved in substrate specificity

  • Structural comparison: Homology modeling using related bacterial aminotransferases can help predict the structure of V. vulnificus argD. This approach is similar to the sequence alignment method used for V. vulnificus NAT with (BACAN)NAT as a template .

What are the implications of iron availability on argD expression and function in Vibrio vulnificus?

Iron availability significantly affects metabolic pathways in V. vulnificus. Based on transcriptomic analyses:

  • Differential expression: Iron-replete and iron-deplete conditions lead to distinct transcriptomic profiles in V. vulnificus, potentially affecting argD expression. In iron-replete conditions, V. vulnificus shows upregulated overflow metabolism genes, which may indirectly affect amino acid biosynthesis pathways .

  • Regulatory networks: The anaerobic respiration global regulator arcA is upregulated when iron is available, and this transcription factor may influence arginine metabolism pathways including argD expression .

  • Experimental approach: To study iron effects on argD expression:

    • Culture V. vulnificus in iron-replete (supplemented with FeCl3) and iron-deplete (with iron chelator like 2,2'-dipyridyl) media

    • Perform qRT-PCR targeting argD

    • Analyze enzyme activity using purified recombinant protein under varying iron concentrations

How should I design experiments to study the kinetic properties of recombinant Vibrio vulnificus argD?

Designing kinetic experiments for recombinant V. vulnificus argD requires careful planning:

  • Enzyme assay selection: For argD, a coupled assay system is recommended:

    • Primary reaction: N-acetylornithine + α-ketoglutarate → N-acetylglutamate semialdehyde + glutamate

    • Detection: Measure glutamate formation using glutamate dehydrogenase and NAD+/NADH absorbance change at 340nm

  • Experimental conditions optimization:

    • pH range: Test pH 7.0-9.0 (50 mM potassium phosphate or Tris-HCl buffers)

    • Temperature range: 25-37°C

    • Substrate concentrations: N-acetylornithine (50-800 μM) and α-ketoglutarate (50-800 μM)

  • Data collection for Michaelis-Menten kinetics:

    • Initial velocity measurements at different substrate concentrations

    • Determine Km and Vmax using non-linear regression

    • Analyze using Lineweaver-Burk or Eadie-Hofstee plots

Table 1. Sample experimental design for argD kinetic analysis:

ParameterCondition Set 1Condition Set 2Condition Set 3
pH7.58.08.5
Temperature25°C30°C37°C
Substrate ranges50-800 μM50-800 μM50-800 μM
Enzyme concentration0.5 μg/mL0.5 μg/mL0.5 μg/mL
Buffer50 mM K-phosphate50 mM K-phosphate50 mM K-phosphate
PLP concentration50 μM50 μM50 μM

Similar approaches have been successfully employed for kinetic characterization of other V. vulnificus enzymes such as NAT .

What is the most appropriate experimental design to study the effects of environmental conditions on argD activity?

To investigate environmental effects on argD activity, a completely randomized design (CRD) or randomized block design (RBD) approach is recommended:

  • CRD approach:

    • Suitable when experimental units are homogeneous

    • Randomly allocate treatments to experimental units

    • Best for controlled laboratory conditions

  • Factors to investigate:

    • Temperature (20°C, 25°C, 30°C, 37°C)

    • pH (6.5, 7.0, 7.5, 8.0, 8.5)

    • Salinity (0.5%, 1%, 2%, 3% NaCl)

    • Oxygen availability (aerobic vs. anaerobic)

  • Analysis methods:

    • ANOVA for statistical significance

    • Tukey's HSD for post-hoc comparisons

    • Multiple regression for interactions between factors

  • Data presentation:

    • Three-dimensional response surface plots

    • Heat maps showing activity profiles across conditions

What is the optimal purification protocol for recombinant Vibrio vulnificus argD?

The following purification protocol is recommended for recombinant V. vulnificus argD:

  • Cell lysis:

    • Harvest cells by centrifugation (5,000 × g, 15 min, 4°C)

    • Resuspend in lysis buffer (50 mM Tris-HCl pH 8.0, 300 mM NaCl, 10 mM imidazole, 1 mM PMSF, 5 μM PLP)

    • Disrupt cells by sonication or French press

    • Clear lysate by centrifugation (20,000 × g, 30 min, 4°C)

  • Immobilized metal affinity chromatography (IMAC):

    • Apply clarified lysate to Ni-NTA column

    • Wash with buffer containing 20 mM imidazole

    • Elute with buffer containing 250 mM imidazole

  • Size exclusion chromatography:

    • Apply concentrated IMAC fractions to Superdex 200 column

    • Elute with 50 mM Tris-HCl pH 8.0, 150 mM NaCl, 5 μM PLP

  • Quality control:

    • SDS-PAGE analysis (expected molecular mass ~45 kDa)

    • Western blot using anti-His antibodies

    • Activity assay to confirm function

This approach is similar to successful purification strategies used for other V. vulnificus enzymes, such as NAT, which was purified to study its enzymatic properties .

How can I assess the substrate specificity of Vibrio vulnificus argD?

To comprehensively assess substrate specificity:

  • Substrate panel preparation:

    • Primary substrates: N-acetylornithine, N-succinylornithine

    • Alternative amino group donors: ornithine, lysine, arginine

    • Alternative keto acid acceptors: α-ketoglutarate, pyruvate, oxaloacetate

  • Activity assay methods:

    • Direct assay: HPLC detection of reaction products

    • Coupled assay: Glutamate dehydrogenase system for α-ketoglutarate-utilizing reactions

    • Spectrophotometric assay: Monitor PLP-associated spectral changes

  • Kinetic parameter determination:

    • Measure reaction rates at varying substrate concentrations

    • Calculate Km, kcat, and catalytic efficiency (kcat/Km) for each substrate

    • Generate comparative bar graphs of catalytic efficiency

This systematic approach is similar to substrate specificity studies performed for V. vulnificus NAT, which demonstrated particular substrate specificity towards aromatic substrates using the DTNB method .

How do I address inconsistent activity measurements when working with recombinant argD?

Inconsistent activity measurements are common challenges when working with recombinant aminotransferases. Address these issues systematically:

  • Enzyme stability assessment:

    • Perform thermal stability analysis using differential scanning fluorimetry

    • Test enzyme stability at different protein concentrations (similar to the approach used for V. vulnificus NAT, which showed poor colloidal stability at higher concentrations)

    • Add glycerol (10-20%) to storage buffers to improve stability

  • Cofactor considerations:

    • Ensure consistent PLP incorporation by supplementing all buffers with 5-50 μM PLP

    • Pre-incubate enzyme with PLP before activity measurements

    • Monitor PLP binding spectrophotometrically (peak at ~410 nm)

  • Metal effects evaluation:

    • Test for inhibitory effects of common metal ions (similar to V. vulnificus NAT, which was significantly inhibited by Zn2+ and Cu2+)

    • Include 1-5 mM EDTA in assay buffers to chelate potential inhibitory metals

  • Statistical approach:

    • Implement randomized block design to control for batch-to-batch variation

    • Use at least 3-5 technical replicates and 3 biological replicates

    • Apply appropriate statistical tests (ANOVA with post-hoc analysis)

What computational approaches can help identify potential regulatory elements affecting argD expression?

To identify regulatory elements affecting argD expression:

  • Promoter analysis:

    • Extract 500 bp upstream region of argD gene

    • Use MEME, JASPAR, or other motif discovery tools to identify potential transcription factor binding sites

    • Cross-reference with known V. vulnificus regulatory elements

  • Transcriptome data mining:

    • Analyze RNA-seq data under different conditions (similar to the approach used in studying V. vulnificus ENV1 under iron-replete and iron-deplete conditions)

    • Identify co-expressed genes to determine potential operons

    • Perform differential expression analysis to identify conditions affecting argD

  • Network analysis:

    • Construct metabolic and regulatory networks using Cytoscape

    • Integrate argD into amino acid metabolism pathways

    • Identify potential cross-talk with other metabolic pathways (e.g., acetate metabolism in V. vulnificus)

  • Validation experiments:

    • Design reporter gene assays using predicted promoter regions

    • Perform ChIP-seq to identify transcription factors binding to argD regulatory regions

    • Use CRISPR interference to validate regulatory elements

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.